Microsoft reportedly considers canceling Marvel’s Blade and closing Arkane

Microsoft is weighing whether to cancel Marvel’s Blade and shut down Arkane, a move that would pull one of Xbox’s most visible superhero projects off the board just as the company reshapes its game business. Arkane is one of five studios Microsoft is considering closing, which makes Blade part of a much wider internal reset.

Marvel’s Blade was unveiled at The Game Awards on December 7, 2023 as a mature, single-player, third-person game set in Paris and built by Arkane Lyon. Bethesda and Marvel did not announce a release date or platforms at the reveal, but the pitch was clear enough to stand out immediately: a marquee licensed title built with Arkane’s usual emphasis on atmosphere and authored design.

The contrast with what came later is what makes the current situation so stark. Todd Howard said in May 2026 that he had seen the game and that Arkane was doing a “really, really great job.” Even so, the project’s internal release target is said to have slipped from late 2026 to late 2027, and the game has gone over budget. That combination leaves Blade vulnerable at a moment when Microsoft is already making broader cuts across its Xbox operation.

If Microsoft does move ahead, the impact reaches well beyond one Marvel project. Blade would disappear from the release calendar before ever reaching players, and Xbox would lose another high-profile title that had been meant to broaden the slate beyond its biggest internal brands. For Arkane, the stakes are higher still. A shutdown would put one of Xbox’s most storied studios, the team behind Dishonored and Deathloop, into the company’s growing list of casualties from 2026’s restructuring wave.

That is the real story hanging over Blade now. A game that began as one of Xbox’s most eye-catching licensed bets could instead become the clearest sign yet that Microsoft’s tolerance for long-cycle prestige projects has tightened, even when the project carries Marvel’s name and a studio like Arkane behind it.